Speaker 1: Global business news twenty four hours a day. If Bloomberg
Speaker 1: dot Com, the radio plus mobile APT and on your radio.
Speaker 1: This is a Broomberg business flash from Bloomberg World Handquarters.
Speaker 1: I'm Charlie, Peta dal the SMP, Nestack or all Trading Laurel.
Speaker 1: Let's head right over to the first word breaking news
Speaker 1: desk for today's afternoon call. Here he is. He's back,
Speaker 1: Bill Maloney, Good afternoon, Charlie. That's right. In the US,
Speaker 1: averages are lower today in a quiet session, with the
Speaker 1: Doubt currently down thirty two points, SP dropped four in,
Speaker 1: NAZAC is down fourteen. The small cap six hundred is
Speaker 1: lower by a point, and the US ten yield at
Speaker 1: one point five eight percent. Eight out of tennis B
Speaker 1: sectors are lower, led by losses in healthcare, telcom and
Speaker 1: consumer Discretionary. Energy and materials lead down. Transports are a
Speaker 1: little change and as a BOTTEX drop thirty eight. Utilities
Speaker 1: fall a point, and the VIX is higher by one
Speaker 1: point eight percent. Deal leaders said the downside included Mark
Speaker 1: Fiser and mcdonal, while the leaders included ex On Mobile,
Speaker 1: Caterpillar and Chevron. Bristol Myers fell another four and a
Speaker 1: half percent after Friday's six percent decline, while Southby sowed
Speaker 1: as much as twenty three percent. That's in most since
Speaker 1: after its results. Live from the first breaking news dask
Speaker 1: On boll maloney, Charlie, all right, thank you very much,
Speaker 1: and to hear live breaking news over your Bloomberg type
Speaker 1: squawk as Q you a w K on your terminal.
Speaker 1: I'm Charlie Pollock. That's a bloom Bird business flash. Now
Speaker 1: on Bloomberg Radio, we take stock of healthcare. The issue
Speaker 1: of drug pricing has been at the forefront, certainly in
Speaker 1: the political realm for the last few months. We're living
Speaker 1: in a very special time in the history of the
Speaker 1: pharmaceutical industry, and the three percent of all biotechs that
Speaker 1: start actually get the drug approved. It's a very hard
Speaker 1: thing to do. Bloomberg taking sto healthcare and focus on
Speaker 1: Bloomberg Radio. If you happened to be in a San
Speaker 1: Diego over the last couple of days, the world's largest
Speaker 1: gathering of life extension enthusiasts was held. World prodowned futurist
Speaker 1: and inventor Ray Kurzweil, one of the creators of optical
Speaker 1: character readers that delivered the keynote address here to help
Speaker 1: us understand more about life extension enthusiasts is Bill Falloon.
Speaker 1: He is the co founder of the Life Extension Foundation. Bill,
Speaker 1: thanks very much for being with me. Appreciated greatly. First
Speaker 1: time in medical history, for the first time ever, multiple
Speaker 1: methods of inducing meaningful human age reversal were presented. I've
Speaker 1: been working at this my whole life. Never happened before. Bill.
Speaker 1: Before we get into the details of what was said
Speaker 1: or presented at the gathering, I wonder if you could
Speaker 1: explain to people that are not familiar with the term
Speaker 1: life extension, what does it encompass. Up until now, life
Speaker 1: extension meant taking steps to slow down your rate of
Speaker 1: biological aging and reduce your risk of degenerative disease. That's
Speaker 1: up until now. But that's all changed. We are now
Speaker 1: looking at ways to reverse biological aging. And we saw
Speaker 1: people presenting the results of their clinical studies, meaning human
Speaker 1: studies showing meaningful age reversal. It's it's unprecedented, and we
Speaker 1: believe it's going to launch an entire new market. Before
Speaker 1: we get into that, maybe you could just explain this
Speaker 1: age reversal study in the context of genetic analysis. Well,
Speaker 1: let me let me just give you. There was many,
Speaker 1: many presentations different ways of inducing age reversal. But what
Speaker 1: we normally try to look at our factors such as
Speaker 1: endothelial function, in other words, how healthy is your arterial system.
Speaker 1: We look at lipid levels, glucose, We look at the insulin.
Speaker 1: Older people have too much of it. So we look
Speaker 1: at a broad odd range what we call bio markers
Speaker 1: of aging, including whatever genetics we can find, but those
Speaker 1: have not been totally validated yet. But in study after study,
Speaker 1: they're seeing regeneration in vital tissues and organs in response
Speaker 1: to therapies that have worked animals but have never been
Speaker 1: attested in humans before. And we were able to put
Speaker 1: all of these sciences together in one conference over three
Speaker 1: and a half days, and we gave him each about
Speaker 1: fifteen minutes to present, and we brought someone else back
Speaker 1: on UH to show us what they were doing to
Speaker 1: reverse aging. What is the Crisper system and how does
Speaker 1: that relate to this topic. That is the most promising
Speaker 1: technology there is. Crisper cast nine is being studied by
Speaker 1: Dr George Church at Harvard University. He predicted in The
Speaker 1: Washington Post published in December two thousand fifteen that human
Speaker 1: beings will be able to reverse their aging process using
Speaker 1: Crisper cast nine with then the next five years. We're
Speaker 1: wildly enthusiastic about that. We did not invite Dr Church
Speaker 1: out there because people in our longevity community we know
Speaker 1: he's doing great work. We hope what he's doing will
Speaker 1: be that silver bullet. But we're not waiting. We're exploring
Speaker 1: many other ways of inducing meaningful reversal of biological aging.
Speaker 1: But can you just give me one example, specifically of
Speaker 1: a therapy or a regiment or any kind of a
Speaker 1: real simple one. There's a protein in the blood called
Speaker 1: g DF eleven that stands for growth differentiating factor eleven
Speaker 1: that also is being studied in animals at Harvard University.
Speaker 1: It induces systemic age reversal in the animal model. There's
Speaker 1: a group of longevity enthusiasts who are using g DF
Speaker 1: eleven on themselves and carefully monitoring a wide range of
Speaker 1: bio markers, and they're all showing significant age reversal with
Speaker 1: one serious side effect, and we will we have to
Speaker 1: overcome that one. And what is the serious side effect?
Speaker 1: Their youthful appetite has been restored. They are over consuming calories.
Speaker 1: They're putting on a little weight in response to them
Speaker 1: eating more food than they know they should be. But
Speaker 1: their sense of smell has been restored. The biomarkers of
Speaker 1: endo fudial function that the blood lipids, the glucose, they're
Speaker 1: all going back to the youthful range. And response to
Speaker 1: just one one intervention, three injections a week of g
Speaker 1: d F eleven is causing these individuals to have their
Speaker 1: aging process go in reverse. And they're being inundated from
Speaker 1: people who say, I want to join your group. What
Speaker 1: is the what is the Food and Drug Administration's response
Speaker 1: to this? Oh, they would just say you can't do it.
Speaker 1: They would say you can't be doing this sort of
Speaker 1: thing that people aren't waiting. This is like the HIV
Speaker 1: community in early nineteen eighties. We're aging to death. We
Speaker 1: can't wait for the FDA to put a rubber stamp
Speaker 1: on something. So these are groups of individuals taking the
Speaker 1: initiative to try to reverse aging and their own bodies
Speaker 1: and and in other cases there are credential DOT doctors
Speaker 1: doing a peer review clinical studies where you do have
Speaker 1: FDA approval. But what was so exciting here were people
Speaker 1: coming up showing the results of technologies where they do
Speaker 1: really have intellectual property interest in it. They were just
Speaker 1: individuals trying to reverse the raging process. In other cases
Speaker 1: there were credential physicians. We've gotta leave it there, we
Speaker 1: gotta run. Bill Falloon, he is the co founder of
Speaker 1: Life Extension Foundation, talking about new techniques to reverse the
Speaker 1: aging process. This is taking stock. I'm Kim Fox. This
Speaker 1: is Bloomberg. Bloomberg. Taking Stock is brought to by Jaguar Manhattan.
Speaker 1: Visit Jaguar Manhattan today, where New York goes for luxury,
Speaker 1: conveniently located at four and eleventh Avenue. Went online at
Speaker 1: Jaguar Manhattan dot com and Jaguar Manhattan is at your service.